Article
Immune mechanisms in malaria: new insights in vaccine development.
Nature medicine - 1 Feb 2013
Riley Eleanor M, Stewart V Ann
Abstract excerpt
Early data emerging from the first phase 3 trial of a malaria vaccine are raising hopes that a licensed vaccine will soon be available for use in endemic countries, but given the relatively low efficacy of the vaccine, this needs to be seen as a major step forward on the road to a malaria vaccine rather than as arrival at the final destination. The focus for vaccine developers now moves to the next generation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
